The rising popularity of GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, has led to an increased demand for plastic surgery procedures. While these drugs were originally developed to treat diabetes, their effectiveness as weight-loss aids has resulted in rapid physical changes for many users, prompting them to seek medical intervention for loose skin and other aesthetic concerns.
According to a report from the American Society of Plastic Surgeons (ASPS), there has been a significant rise in procedures such as facelifts, as well as surgeries targeting the arms, neck, breasts, and thighs. Dr. C. Bob Basu, president of the ASPS, noted that an increasing number of patients are turning to plastic surgeons to complete their weight-loss journeys after using these medications.
Medical professionals have observed that the rapid weight loss associated with these drugs often leaves the skin unable to retract at the same pace, leading to what some have termed Ozempic face. Dr. Daniel Gould, a plastic surgeon in Beverly Hills, stated in May that approximately 70 to 80 percent of his patients are currently using these medications. Similarly, Dr. Alan Matarasso of Manhattan reported that patients frequently consult him regarding changes to their facial appearance following the use of these drugs.
Dr. John Diaz, a plastic surgeon based in Beverly Hills, suggested that individuals concerned about their weight are often already inclined to seek aesthetic improvements, making them more likely to pursue plastic surgery. Experts emphasize that when weight loss occurs rapidly, the skin often lacks the elasticity to adjust, necessitating surgical procedures to address the resulting excess tissue.